Darifenacin

FDA Approved: * July 28, 2017
Pharm Company: * MACLEODS PHARMS LTD
Category: Urinary System

Darifenacin (trade name Enablex in United States and Canada, Emselex in the European Union) is a medication used to treat urinary incontinence due to an overactive bladder.[1][2][3] It was discovered by scientists at the Pfizer research site in Sandwich, UK under the identifier UK-88,525 and used to be marketed by Novartis. In 2010, the US rights were sold to Warner Chilcott for US$400 million. Contents 1 Adverse effects 2 Medical uses 3 Mecha... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
2 Discussions

Dosage List

Darifenacin 7.5 mg Oral Tablet, Extended Release
NDC: 0591-4375
Labeler:
Actavis Pharma, Inc.
Darifenacin 15 mg Oral Tablet, Extended Release
NDC: 0591-4380
Labeler:
Actavis Pharma, Inc.
Darifenacin Hydrobromide Extended-release 7.5 mg Oral Tablet, Extended Release
NDC: 10370-170
Labeler:
Par Pharmaceutical
Darifenacin Hydrobromide Extended-release 15 mg Oral Tablet, Extended Release
NDC: 10370-171
Labeler:
Par Pharmaceutical
Darifenacin 7.5 mg Oral Tablet, Extended Release
NDC: 13668-202
Labeler:
Torrent Pharmaceuticals Limited
Darifenacin 15 mg Oral Tablet, Extended Release
NDC: 13668-203
Labeler:
Torrent Pharmaceuticals Limited
Darifenacin 7.5 mg Oral Tablet, Film Coated, Extended Release
NDC: 16571-767
Labeler:
Rising Pharma Holdings, Inc.
Darifenacin 15 mg Oral Tablet, Film Coated, Extended Release
NDC: 16571-768
Labeler:
Rising Pharma Holdings, Inc.
Darifenacin 7.5 mg Oral Tablet, Extended Release
NDC: 33342-276
Labeler:
Macleods Pharmaceuticals Limited
Darifenacin 15 mg Oral Tablet, Extended Release
NDC: 33342-277
Labeler:
Macleods Pharmaceuticals Limited
More Results

Related Brands

Drugs with the same active ingredients

Popular Topics

drug darifenacin

is the drug derifenacin useful in chronic cystitis...

Enablex-darifenacin

Prostate Condition...